ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2017. The put-call ratio across all filers is 319.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,475,747 | -8.4% | 2,697,084 | +3.8% | 0.00% | 0.0% |
| Q2 2023 | $5,975,689 | -13.8% | 2,598,126 | +13.6% | 0.00% | 0.0% |
| Q1 2023 | $6,932,376 | +139524.9% | 2,287,913 | +7.3% | 0.00% | 0.0% |
| Q4 2022 | $4,965 | -99.9% | 2,131,268 | +6.0% | 0.00% | 0.0% |
| Q3 2022 | $3,838,000 | -20.7% | 2,009,840 | +12.6% | 0.00% | 0.0% |
| Q2 2022 | $4,837,000 | -6.2% | 1,785,042 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $5,155,000 | -20.6% | 1,729,978 | +3.6% | 0.00% | 0.0% |
| Q4 2021 | $6,494,000 | -1.7% | 1,669,624 | +8.4% | 0.00% | 0.0% |
| Q3 2021 | $6,608,000 | +69.5% | 1,540,431 | +19.7% | 0.00% | 0.0% |
| Q2 2021 | $3,898,000 | +119.0% | 1,286,658 | +140.7% | 0.00% | – |
| Q1 2021 | $1,780,000 | +24.9% | 534,582 | +33.1% | 0.00% | – |
| Q4 2020 | $1,425,000 | +19.7% | 401,651 | +5.6% | 0.00% | – |
| Q3 2020 | $1,190,000 | +109.1% | 380,377 | +21.5% | 0.00% | – |
| Q2 2020 | $569,000 | +422.0% | 313,030 | +188.8% | 0.00% | – |
| Q1 2020 | $109,000 | -84.6% | 108,396 | -57.5% | 0.00% | – |
| Q4 2019 | $708,000 | +521.1% | 255,026 | +239.5% | 0.00% | – |
| Q3 2019 | $114,000 | -28.3% | 75,126 | -2.0% | 0.00% | – |
| Q2 2019 | $159,000 | -83.1% | 76,695 | -70.8% | 0.00% | – |
| Q1 2019 | $941,000 | -47.9% | 262,990 | -44.3% | 0.00% | – |
| Q4 2018 | $1,806,000 | +3.4% | 471,864 | +155.3% | 0.00% | – |
| Q3 2018 | $1,746,000 | +93.4% | 184,805 | +49.3% | 0.00% | – |
| Q2 2018 | $903,000 | +1171.8% | 123,788 | +767.6% | 0.00% | – |
| Q1 2018 | $71,000 | -1.4% | 14,268 | 0.0% | 0.00% | – |
| Q4 2017 | $72,000 | -57.1% | 14,268 | -47.4% | 0.00% | – |
| Q3 2017 | $168,000 | +73.2% | 27,115 | 0.0% | 0.00% | – |
| Q2 2017 | $97,000 | +9.0% | 27,115 | -1.4% | 0.00% | – |
| Q1 2017 | $89,000 | +36.9% | 27,493 | +3.2% | 0.00% | – |
| Q4 2016 | $65,000 | -27.0% | 26,635 | +2.2% | 0.00% | – |
| Q3 2016 | $89,000 | -1.1% | 26,063 | +0.6% | 0.00% | – |
| Q2 2016 | $90,000 | +8.4% | 25,920 | +28.3% | 0.00% | – |
| Q1 2016 | $83,000 | -7.8% | 20,203 | -0.7% | 0.00% | – |
| Q4 2015 | $90,000 | -26.2% | 20,346 | +1.4% | 0.00% | – |
| Q3 2015 | $122,000 | – | 20,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |